Needham analyst Kyle Peterson initiates coverage on First Advantage (NASDAQ:FA) with a Hold rating.
These Two Companies Plan To Do A Real-World Evidence Study On Efficacy Of CBG Transdermal Gel On Pain And Inflammation
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) will be initiating an observational real-world evidence study using RHO Phyto branded Cannabigerol (“CBG”) transdermal gel on patients with musculoskeleta
